Related Experiment Video
Updated: Aug 19, 2026
11:08
Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
HIV-associated lymphoma: promising new results, but with toxicity
1Memorial Sloan-Kettering Cancer Center.
Blood
|March 5, 2005
Abstract:
Treatment of HIV-associated non-Hodgkin lymphoma with rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide resulted in high complete remission and 2-year failure free and overall survival rates but a high rate of infection.
